MRI-SWI as a Predictor of Functional Outcome in Acute Ischemic Stroke

Sponsor
Taipei Medical University WanFang Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT00696306
Collaborator
(none)
30
1
36
0.8

Study Details

Study Description

Brief Summary

The purpose of the study is to use diffusion tensor imaging (DTI) derived axial diffusivity and susceptibility weighted imaging (SWI) to evaluate the severity of acute ischemic stroke and to predict its functional outcome.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Stroke is the second leading cause of death in Taiwan. The morbidity and mortality of stroke is also very high worldwide. In the United States, about one third of 800,000 stoke patients became disabled; while in Taiwan, 13,000 out of 68,000 stroke patients died each year.

    Diffusion tensor imaging (DTI) characterizes the three-dimensional distribution of water diffusion, which is highly anisotropic. Previous studies utilized DTI derived mean diffusivity (MD) and fractional anisotropy (FA) have found correlation between pathological changes of white matter and prognosis of stroke. However, the result was not specific due to the reason that any change at either axon or myelin sheath resulted in FA reduction. DTI, on the other hand, differentiate morphological change at axon and myelin sheath with axial and radial diffusivity, respectively. With this data, we hypothesized that the prognosis might be more relevant to pathological change with axon post-stroke when compare to Diffusion-Weighted imaging (DWI)/Apparent Diffusion Coefficient (ADC).

    Susceptibility-weighted imaging (SWI) is a newer technique which use fully velocity compensation gradient echo sequence to receive magnitude and phase imaging. SWI can be used to detect early phase bleed, intra-arterial thrombus, cerebral venous thrombosis, thus evaluate the prognosis of patients by detect leptomeningeal collateral circulation and intravascular deoxygenation changes. We hypothesized that the prognosis is better in post-stroke patients with preserved leptomeningeal collateral circulation and venous circulation of large blood vessel. Therefore, we conduct the study to use DTI derived axial diffusivity and SWI to evaluate the severity and to predict the functional outcome in acute ischemic stroke patient.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    30 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    Diffusion Tensor Imaging (DTI) and Susceptibility Weighted Imaging (SWI) as a Predictor of Functional Outcome in Acute Ischemic Stroke
    Study Start Date :
    Feb 1, 2008
    Actual Primary Completion Date :
    Feb 1, 2011
    Actual Study Completion Date :
    Feb 1, 2011

    Outcome Measures

    Primary Outcome Measures

    1. To correlate the prognosis of acute ischemic stroke with the result of MRI-DTI and the result of SWI. [6 months]

    Secondary Outcome Measures

    1. To establish the DTI/SWI protocol as the biomarker for future research in neurological disorders, such as brain tumor, brain injury, brain developmental disorders, and Multiple Sclerosis. [6 months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Age greater than 20 years

    • Patients with acute pathological changes in CNS within 7 days admitted from outpatient, ER, or inpatient department

    • Confirmed diagnosis of acute ischemic stroke by clinical testings and CT scan performed by a neurologist

    • Signed informed consent from patient

    Exclusion Criteria:
    • Any person with pacemaker, metal implant, claustrophobia, or any other contraindication for MR examination

    • Any person with epilepsy, brain hematomas, brain tumor, or any neurological disease confirmed by CT scan

    • Any other clinical condition which, in the opinion of the principal investigator, would not be suitable for this study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Taipei Medical University-Wan Fang Hospital Taipei Taiwan 116

    Sponsors and Collaborators

    • Taipei Medical University WanFang Hospital

    Investigators

    • Principal Investigator: Chin-I Chen, MD, Taipei Medical University-Wan Fang Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00696306
    Other Study ID Numbers:
    • 2007WFCRC-002
    First Posted:
    Jun 12, 2008
    Last Update Posted:
    Apr 12, 2011
    Last Verified:
    Apr 1, 2011

    Study Results

    No Results Posted as of Apr 12, 2011